Tag: Kerecis
Coloplast makes changes to executive leadership team
August 18, 2026HME News Staff
MINNEAPOLIS – Coloplast has announced that Fertram Sigurjonsson will transition from his role as executive vice president of Wound & Tissue Repair and a member of the executive leadership team to a new strategic role as Chief Innovation & Technology Advisor to the CEO. In his new role, which is effective immediately, Sigurjonsson will focus on advancing Coloplast’s innovation agenda, particularly within biologics, advanced wound care and emerging technologies. “I remain as passionate...
In brief: ADS taps Bill Mixon as CEO, Coloplast buys Kerecis
July 12, 2023HME News Staff
CARLSBAD, Calif. - Advanced Diabetes Supply has appointed Bill Mixon, who previously led National Seating & Mobility, as its CEO.
The announcement follows the transition of the company’s co-founders and co-CEOs, Mark Howard and Tim Cady, to strategic advisory roles as members of the board of directors.
“Bill has provided valuable insight and support to the ADS leadership team as a board member for the last two years,” said Jeffrey Abramoff, a partner at Court Square,...
Coloplast expands into biologics wound care segment
July 10, 2023HME News Staff
MINNEAPOLIS – Coloplast has signed an agreement to buy Kerecis, a biotech company based in Iceland that is pioneering the use of fish skin in the regenerative medicine market, for up to $1.3 billion.
Coloplast will pay $1.2 billion upfront on a cash and debt-free basis and will pay up to a $100 million earnout dependent on financial performance in fiscal year 2023-24.
“The advanced wound care market holds significant untapped potential, and today Coloplast is only present...